Author: Rebecca Shover
How AI Applications Will Transform Healthcare
Apr 4, 2023
Natural language processing (NLP), the ability for computers and humans to communicate in a more...
Read MoreProtect Yourself by Understanding Medical Malpractice Insurance
Apr 3, 2023
No matter how adept a physician is in their field, one key element to achieving and maintaining a...
Read MoreOral Immunotherapy Desensitizes Non-Milk Food Allergies in Adults
Mar 31, 2023
Although food allergies are a common pediatric concern, there are many adults who live with them...
Read MoreBlockade of the IL-22 Receptor: Novel Treatment Approach in AD
Mar 29, 2023
IL-22 might be a novel target in the therapy of moderate-to-severe atopic dermatitis (AD). In a...
Read MoreBiomarkers Assessments May Be Useful to Identify Treatment Response for CSU
Mar 29, 2023
Certain biomarkers in patients with chronic spontaneous urticaria (CSU) may predict the treatment...
Read MoreNovel Potent Oral Medication for Psoriasis Proves Efficacious
Mar 29, 2023
A novel tyrosine kinase 2 (TYK2) inhibitor showed remarkable efficacy as a treatment for psoriasis...
Read MoreRisankizumab: Valuable Treatment Option for IL-17 Inhibitor Non-Responders
Mar 29, 2023
Results of the AIMM study show that switching patients that show suboptimal response on an IL-17...
Read MoreTopical Roflumilast Offers Early Itch Reduction in Atopic Dermatitis
Mar 29, 2023
For pediatric and adult patients with mild-to-moderate AD, roflumilast cream demonstrated a...
Read MoreDeuruxolitinib Shows Promising Results in Alopecia Areata
Mar 29, 2023
Oral deuruxolitinib revealed significantly higher rates of hair re-growth than placebo in patients...
Read MoreBimekizumab: The New Rising Star for HS Therapy?
Mar 29, 2023
Within the BE HEARD trial, bimekizumab treatment resulted in significant benefits in the treatment...
Read MoreRepigmentation Persists After Treatment Withdrawal from Topical Ruxolitinib
Mar 29, 2023
Following the success of a nearly complete re-pigmentation status in vitiligo on ruxolitinib...
Read MoreTopical Delgocitinib Proves Efficacious for Chronic Hand Eczema
Mar 29, 2023
Pan-JAK inhibition with delgocitinib met its primary endpoint in the DELTA 1 trial for the...
Read MoreBaricitinib Offers New Hope for Patients With Lichen Planus
Mar 28, 2023
In more than 90% of patients with lichen planus (LP), response to treatment was observed for...
Read MoreMultidisciplinary Decision Making in Advanced HCC: A Hepatologist’s Perspective
Mar 28, 2023
Along with the latest guidelines from the NCCN and ASCO, the American Association for the Study of...
Read MoreMultidisciplinary Decision Making in Advanced HCC: An Oncologist’s Perspective
Mar 28, 2023
“It is essential that all patients be evaluated by a multidisciplinary team prior to initiation of...
Read MorePrevalence & Clinical Associations of Enthesitis in SLE Examined
Mar 27, 2023
The prevalence and clinical significance of enthesitis in SLE make an argument for the...
Read MoreAs-Needed Ruxolitinib Safe & Effective for Controlling AD Symptoms
Mar 23, 2023
An analysis of two phase 3 trials evaluated the effect of ruxolitinib cream in adult and...
Read MoreBiologics May Impede the Incidence of Psoriatic Arthritis
Mar 23, 2023
In patients with psoriasis, retrospective data revealed that compared with phototherapy, a...
Read More